GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·DELAWARE·Filed: Jun 12, 2020
Total Offering

Indefinite

Amount Sold

$2,417,000

Investors

9

First Sale

Apr 20, 2020

Offering Details

Type
Debt, Other: Debt convertible into equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Anthony Cataldo
Related Person
Steven Weldon
Related Person

Company

GT Biopharma, Inc.

9350 Wilshire Blvd

Beverly Hills, CA, 90212

800-304-9888

SEC Filing

0001654954-20-006561

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free